Current opinion in clinical nutrition and metabolic care
Sodium-glucose transporter inhibitors 2 in acutely ill patients.
Fernando G Zampieri, Melanie Meersch, Emily See
Published: 202610.1097/MCO.0000000000001194
Abstract
PURPOSE OF REVIEW: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have rapidly become central to the management of heart failure and chronic kidney disease. Their widespread use now extends into the peri-acute and critical-care setting, raising q…
Preview only. Read the full abstract at the source